| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.035 | 0.5 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.5 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.037 | 0.5 |